Dime Time Extended Release Interactions
There are 489 drugs known to interact with Dime Time Extended Release (brompheniramine / phenylephrine / phenylpropanolamine), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 69 are major, 417 are moderate, and 3 are minor.
- View all 489 medications that may interact with Dime Time Extended Release
- View Dime Time Extended Release alcohol/food interactions (2)
- View Dime Time Extended Release disease interactions (9)
Most frequently checked interactions
View interaction reports for Dime Time Extended Release (brompheniramine / phenylephrine / phenylpropanolamine) and the medicines listed below.
- amlodipine
- amoxicillin / clavulanate
- Armour Thyroid (thyroid desiccated)
- budesonide
- calcium gluconate
- Centrum Silver Women's (multivitamin with minerals)
- cetirizine
- clopidogrel
- CoQ10 (ubiquinone)
- D3 (cholecalciferol)
- hydrochlorothiazide
- Lexapro (escitalopram)
- meclizine
- pantoprazole
- PreserVision (multivitamin with minerals)
- Vitamin B Complex 100 (multivitamin)
- Vitamin C with Rose Hips (ascorbic acid)
- Xanax (alprazolam)
- Zetia (ezetimibe)
- zinc gluconate
Dime Time Extended Release alcohol/food interactions
There are 2 alcohol/food interactions with Dime Time Extended Release (brompheniramine / phenylephrine / phenylpropanolamine).
Dime Time Extended Release disease interactions
There are 9 disease interactions with Dime Time Extended Release (brompheniramine / phenylephrine / phenylpropanolamine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- psychosis
- BPH
- diabetes
- glaucoma
Report options
More about Dime Time Extended Release (brompheniramine / phenylephrine / phenylpropanolamine)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.